Your browser doesn't support javascript.
loading
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes.
Johansson, Lars; Hockings, Paul D; Johnsson, Eva; Dronamraju, Nalina; Maaske, Jill; Garcia-Sanchez, Ricardo; Wilding, John P H.
Afiliación
  • Johansson L; Antaros Medical AB, BioVenture Hub, Mölndal, Sweden.
  • Hockings PD; Antaros Medical AB, BioVenture Hub, Mölndal, Sweden.
  • Johnsson E; Global Medicines Development, AstraZeneca, Gothenburg, Sweden.
  • Dronamraju N; Global Medicines Development, AstraZeneca, Gaithersburg, Maryland, United States.
  • Maaske J; Global Medicines Development, AstraZeneca, Gaithersburg, Maryland, United States.
  • Garcia-Sanchez R; Global Medicines Development, AstraZeneca, Gaithersburg, Maryland, United States.
  • Wilding JPH; Obesity and Endocrinology Research Group, Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom.
Diabetes Obes Metab ; 22(7): 1094-1101, 2020 07.
Article en En | MEDLINE | ID: mdl-32072735
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Metformina Tipo de estudio: Clinical_trials Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2020 Tipo del documento: Article